Hemophilia News and Research

RSS
Hemophilia is a rare, inherited bleeding disorder in which your blood doesn’t clot normally. If you have hemophilia, you may bleed for a longer time than others after an injury. You also may bleed internally, especially in your knees, ankles, and elbows. This bleeding can damage your organs or tissues and, sometimes, be fatal.
Phase 2a clinical trial in nonsense mutation hemophilia A and hemophilia B initiated

Phase 2a clinical trial in nonsense mutation hemophilia A and hemophilia B initiated

Medgenics signs $7 million agreement to develop the Biopump technology for Factor VIII

Medgenics signs $7 million agreement to develop the Biopump technology for Factor VIII

Accredo Health Group announces a 10-year renewal of its headquarters with Memphis

Accredo Health Group announces a 10-year renewal of its headquarters with Memphis

Biogen Idec announces total revenues of $1.12 billion for third quarter 2009

Biogen Idec announces total revenues of $1.12 billion for third quarter 2009

Biogen Idec and Biovitrum to conduct rFIXFc clinical trial in hemophilia B patients

Biogen Idec and Biovitrum to conduct rFIXFc clinical trial in hemophilia B patients

Baxter International announces financial results for third quarter 2009; updates full-year financial outlook

Baxter International announces financial results for third quarter 2009; updates full-year financial outlook

FDA grants marketing approval for CSL Behring's Berinert C1-Esterase Inhibitor

FDA grants marketing approval for CSL Behring's Berinert C1-Esterase Inhibitor

New York Governor participates in roundtable discussion on stem cell research

New York Governor participates in roundtable discussion on stem cell research

Aflac raises $1.16 million through a grant campaign for pediatric cancer treatment

Aflac raises $1.16 million through a grant campaign for pediatric cancer treatment

Baxter receives marketing authorization for CELVAPAN H1N1 pandemic influenza vaccine

Baxter receives marketing authorization for CELVAPAN H1N1 pandemic influenza vaccine

HDSA honors outstanding contributors against Huntington's Disease

HDSA honors outstanding contributors against Huntington's Disease

CSL Behring LEAD program invites grant requests from organizations assisting people with rare diseases

CSL Behring LEAD program invites grant requests from organizations assisting people with rare diseases

NYBC encourages people to organize community blood drives

NYBC encourages people to organize community blood drives

Baxter launches HYLENEX recombinant for pediatric rehydration at the 2009 ACEP

Baxter launches HYLENEX recombinant for pediatric rehydration at the 2009 ACEP

EMEA grants positive opinion for Baxter's CELVAPAN H1N1 pandemic vaccine

EMEA grants positive opinion for Baxter's CELVAPAN H1N1 pandemic vaccine

Amorfix Life Sciences to present Amorfix's EP-vCJD blood screening test for vCJD at WFH Global Forum

Amorfix Life Sciences to present Amorfix's EP-vCJD blood screening test for vCJD at WFH Global Forum

Event to address rheumatoid arthritis

Event to address rheumatoid arthritis

CSL Behring offers new dosage strength of Helixate FS in U.S.

CSL Behring offers new dosage strength of Helixate FS in U.S.

NASDAQ issues noncompliance letter to GTC Biotherapeutics

NASDAQ issues noncompliance letter to GTC Biotherapeutics

Wyeth and Ambrx collaborate to produce the next generation of biologic drugs

Wyeth and Ambrx collaborate to produce the next generation of biologic drugs